Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$14.03M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
425.93%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$3.028M
Q3 2024
Cash
Q3 2024
P/E
-0.4444
Nov 29, 2024 EST
Free Cash Flow
-$8.364M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022
Revenue $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022
Revenue $0.00 $0.00 $0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022
Selling, General & Admin $5.249M $1.333M $13.59M
YoY Change 293.68% -90.19%
% of Gross Profit
Research & Development $2.225M $745.0K $4.100K
YoY Change 198.66% 18070.73%
% of Gross Profit
Depreciation & Amortization $81.00K $0.00
YoY Change
% of Gross Profit
Operating Expenses $12.03M $1.990M $13.59M
YoY Change 504.52% -85.36%
Operating Profit -$12.03M -$1.990M
YoY Change 504.52%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022
Interest Expense $48.00K $95.70K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$3.396M $0.00
YoY Change

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022
Pretax Income -$15.43M -$1.990M -$13.33M
YoY Change 675.18% -85.07%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$15.40M -$2.000M -$12.84M
YoY Change 670.0% -84.43%
Net Earnings / Revenue
Basic Earnings Per Share -$1.05 -$0.17
Diluted Earnings Per Share -$0.82 -$0.09 -$0.61

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022
Cash & Short-Term Investments $8.608M $864.6K $2.044M
YoY Change 895.6% -57.7%
Cash & Equivalents $2.044M
Short-Term Investments
Other Short-Term Assets $783.0K $8.700K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.391M $864.6K $2.053M
YoY Change 986.17% -57.88%
Property, Plant & Equipment $16.00K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $16.00K $0.00 $0.00
YoY Change
Total Assets $9.407M $864.6K $2.053M
YoY Change
Accounts Payable $492.0K $172.5K $91.60K
YoY Change 185.22% 88.32%
Accrued Expenses $285.0K $48.10K $1.600K
YoY Change 492.52% 2906.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $777.0K $220.6K $93.20K
YoY Change 252.22% 136.7%
Long-Term Debt $1.002M $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.002M $0.00 $0.00
YoY Change
Total Liabilities $1.779M $220.6K $93.20K
YoY Change 706.44% 136.7%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022
Basic Shares Outstanding 14.63M 12.02M
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $6.234 Million

About Autonomix Medical, Inc.

Autonomix Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in The Woodlands, Texas and currently employs 5 full-time employees. The company went IPO on 2024-01-29. Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. The company is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES Accelerate Diagnostics, Inc Beyond Air, Inc. CUTERA INC EKSO BIONICS HOLDINGS, INC. FEMASYS INC NEUROONE MEDICAL TECHNOLOGIES Corp Spectral AI, Inc. Neuraxis, INC